Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net (loss) income	$ (103,166)	$ 31,047
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on securities held in Trust Account	(177,418)	(178,921)
Unrealized gain on securities held in Trust Account	(4,451)	(2,184)
Changes in operating assets and liabilities:
Prepaid expenses	(41,542)	(28,723)
Accounts payable and accrued expenses	74,576	39,679
Net cash used in operating activities	(252,001)	(139,102)
Cash flows from investing activities:
Investment of cash in Trust Account	(575,000)	(57,500,000)
Net cash used in investing activities	(575,000)	(57,500,000)
Cash flows from financing activities:
Proceeds from sale of Units, net of underwriting discount paid		55,775,000
Proceeds from sale of Private Units		2,700,000
Proceeds from sale of unit purchase option		100
Proceeds from convertible promissory note	575,000
Proceeds from promissory note - related party	252,447
Repayment of promissory note - related party	(11,048)
Advances from related party		12,821
Payment of offering costs		(363,579)
Net cash provided by financing activities	816,399	58,124,342
Net change in cash	(10,602)	485,240
Cash at beginning of period	11,610	52,937
Cash at end of period	1,008	538,177
Non-cash investing and financing activities:
Initial classification of ordinary shares subject to possible redemption		50,740,740
Change in value of ordinary shares subject to possible redemption	(103,165)	39,438
Offering costs included in accrued offering costs		23,823
Deferred underwriting fee payable		2,012,500
Conversion of advances and short-term promissory notes to long-term promissory notes		$ 415,641